Skip to content

The clinical efficacy comparison between a L-shape collagen stabilized demineralized bovine bone mineral and demineralized bovine bone mineral in horizontal ridge augmentation in anterior region: a prospective, single-blinded, controlled randomized study

The clinical efficacy comparison between a L-shape collagen stabilized demineralized bovine bone mineral and demineralized bovine bone mineral in horizontal ridge augmentation in anterior region: a prospective, single-blinded, controlled randomized study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068228
Enrollment
Unknown
Registered
2023-02-10
Start date
2023-02-15
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

horizontal bone defect in the anterior region (Class IV by Cawood-Howell, Type 1/4 or Type 2/4 by Terheyden)

Interventions

L-shape Bio-Oss Collagen group (test group):A L-Shape Technology will be used in the test group, the Geistlich Bio-Oss Collagen will be trimmed as a L shape to put on the top of Geistlich Bio-Oss with
GBR group (control group):Guided bone regeneration with Bio-Oss and Bio-Gide

Sponsors

School and Hospital of Stomatology, Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. With favorable type of horizontal bone defect (Class IV by Cawood-Howell, Type 1/4 or Type 2/4 by Terheyden) who have been missing the tooth for more than 3 months and need horizontal bone augmentation and implant restoration; 3. Bone defect involving a single tooth in the anterior region; 4. No history of bisphosphonate use.

Exclusion criteria

Exclusion criteria: 1. With cardiovascular and cerebrovascular-related systemic diseases who cannot tolerate surgery; 2. Heavy smokers (>= 20 cigarettes/day); 3. With psychiatric diseases; 4. Pregnant and lactating women; 5. With acute inflammation of adjacent teeth or uncontrollable periodontal diseases.

Design outcomes

Primary

MeasureTime frame
Change of horizontal bone thickness at the lines perpendicular to the implant's long axis at the implant shoulder (HT0) of the augmented region via CBCT images;

Secondary

MeasureTime frame
Change of HT2 (the lines perpendicular to the implant's long axis at 2mm below the shoulder) of the augmented regions;Change of HT4 (the lines perpendicular to the implant's long axis at 4mm below the shoulder) of the augmented regions;Vertical thickness (VT, following the long axis of the coronal portion of the implant);45° vertical thickness (45-VT, at a 45° positive angle relative to the long axis of the coronal portion of the implant);Early postoperative discomfort and wound healing;Implant Stability of the augmented sites via PTV value;PES and WES;

Countries

China

Contacts

Public ContactJing Lan

Shandong University / School and Hospital of Stomatology, Shandong University

kqlj@sdu.edu.cn+86 13964011826

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026